Seminarreihe / 25. Juni 2020, 15:00 Uhr
Effectiveness and Efficacy of R&D Subsidies: Estimating Treatment Effects with One-sided Noncompliance
In evaluating the effectiveness of R&D subsidies, the literature so far has completely neglected the possibility of misappropriation of public funds. This paper contributes to the literature by identifying misappropriation and evaluating the causal effect of R&D subsidies on R&D expenditures when monitoring is weak and misappropriation takes place due to moral hazard behavior. Our analysis is based on Chinese firm-level data for the period 2001-2011. Misappropriation is a major concern as we calculate that 42% of grantees misused R&D subsidies, corresponding to 53% of the total amount of R&D subsidies. Due to one-sided noncompliance to funding contract rules, we differentiate between the intention-to-treat (ITT) effect and the complier average causal effect (CACE). The ITT shows how effective the R&D policy is in practice when misappropriation exists. The CACE, in contrast, depicts how effective it could have been without misappropriation and thus is a measure for the efficacy of the R&D subsidy policy. Combining entropy balancing and IV methods, the ITT estimates show mild partial crowding out of private R&D expenditures. Most strikingly, however, the CACE turns out to be more than twice as large as the ITT and confirms additionality of R&D subsidies. Thus, misappropriation of public funds considerably undermines the efficacy of Chinese R&D programs.
Der Vortrag findet auf Englisch und online statt, bitte klicken sie am 25. Juni ab 15 Uhr auf diesen Link, um teilzunehmen.